AI Article Synopsis
- This study assesses the effectiveness of pars plana vitrectomy in treating uveal effusion syndrome in six patients who underwent various surgical procedures, including internal drainage and photocoagulation.
- All cases resulted in retinal reattachment, but complications were noted in the nanophthalmic cases, including the need for additional surgery and one case of subchoroidal hemorrhage.
- The findings suggest that vitrectomy is beneficial for non-nanophthalmic uveal effusion, enhancing visual outcomes, whereas nanophthalmic cases may require sclerostomy as a preliminary step.
Article Abstract
Purpose: To evaluate the efficacy of pars plana vitrectomy for uveal effusion syndrome retrospectively.
Subjects And Methods: Six patients (six eyes) with uveal effusion syndrome(UE) underwent vitrectomy followed by internal drainage of subretinal fluid, fluid-gas exchange, and pan-retinal photocoagulation. Three of these cases with nanophthalmos underwent silicone oil injection.
Results: The retina became reattached in all cases. The silicone oil was not removed in two of the three cases with nanophthalmic eyes. Two cases of the three cases with nanophthalmic eyes needed to perform full thickness sclerostomy additionally, and in one case subchoroidal hemorrhage occurred. The visual acuity finally improved in five out of the six eyes.
Conclusions: In cases of uveal effusion without nanophthalmic, vitrectomy hastens quick reattachment of the retina and may result in better visual outcome. But in cases of nanophthalmic eyes, it would be better to perform sclerostomy first.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!